How to Navigate the Future Parallel HTA and EMA Processes in the EU

This course will discuss regulatory preparedness for the JCA process, explain the interface between regulators and EU HTA Coordination Group and which information is shared by the two. The instructors have been very close to the HTA Regulation implementation activities in companies and with the policymakers.

Early-Bird rate for DIA Industry Members Available!

DAYS

HOURS

MINUTES

SECONDS

Send Email +41 61 225 51 51

Continuing Education

All DIA training courses have been awarded a PharmaTrain Centre Recognition.

PharmaTrain Federation is a not for profit organisation that started its activities as an IMI (Innovative Medicines Initiative) European Project. Its mission is to drive implementation of globally recognized high-level standards for postgraduate education and training in Medicines Development. To that aim, the Federation is assessing Continuous Professional Development (CPD) Courses and Course Providers around the world that deserve recognition.

The Swiss Association of Pharmaceutical Professionals (SwAPP) and the Swiss Society for Pharmaceutical Medicine (SGPM) have accredited this training course with 3 credits.
Special rates available for SwAPP and SGPM members.

Name	Credit Type	Max Credits	CEU
HTA Regulation impact, 17 Mar 2025, Basel, CH	Credit TypeSWAPP/SGPM	Max Credits3.00	CEU0.000

Statement of Credit:

Please note: Most EU countries accept direct submission, by the participant, of training courses, conferences and other educational opportunities with the aim of obtaining CPD (Continuous Professional Development) points. Please do not hesitate to contact DIA directly if you need any further documentation (e.g. detailed program, certificate of completion, etc.) to conclude your submission.

Have an account?

Download registration form Register Now (Credit Card)

How to Navigate the Future Parallel HTA and EMA Processes in the EU

Continuing Education

Statement of Credit:

Be informed and stay engaged.